Mar 31, 2026 | Data Analytics, New Technology
Artificial intelligence has become a fixture in pharmaceutical strategy conversations. Nearly every major organization has invested in it in some form, whether through internal teams, external partnerships, or acquisitions. The expectation is clear: AI should...
Feb 28, 2026 | Data Analytics, Industry Trends, Market Scan, New Technology
Examining the innovation-to-risk balance among the pharmaceutical industry’s top companies In our previous post, we evaluated the pharmaceutical industry’s leading companies in terms of overall R&D pipeline strength, resulting in Roche, AstraZeneca, Bristol-Myers...
Oct 26, 2025 | Business, Data Analytics, Industry Trends, Market Scan, New Technology, Probability of Success
The leaders, the contenders, and the strategies for success As we approach the 4th quarter of 2025, let’s review where the pharmaceutical industry’s leading companies rank in terms of overall pipeline strength. Roche, AstraZeneca, and Bristol-Myers Squibb sit in a...
Jan 27, 2024 | Business, Data Analytics, Diabetes, Disease Area Trends
Merck’s two blockbuster diabetes products, Janumet® and Januvia®, are DPP-4 inhibitors that generated nearly $3.3 billion in Sales in 2016.3 Januvia® is especially known for its great cardiovascular safety profile, which has helped differentiate itself in its class....
